Cancer of the pancreas.

[1]  C. Mcginn,et al.  Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas , 2003, Journal of Gastrointestinal Surgery.

[2]  J. Neoptolemos,et al.  PHASE III RANDOMISED COMPARISON OF GEMCITABINE (GEM) WITH GEMCITABINE PLUS CAPECITABINE (GEM-CAP) IN PATIENTS WITH ADVANCED PANCREATIC CANCER , 2005 .

[3]  H. Oettle,et al.  A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer , 2005 .

[4]  R. Labianca,et al.  Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  F. Viret,et al.  [How to improve treatment of resectable pancreatic adenocarcinomas? Surgical resection, histopathological examination, adjuvant therapies]. , 2004, Gastroenterologie clinique et biologique.

[6]  M. Giovannini,et al.  Comment améliorer le traitement des adénocarcinomes de la tête du pancréas résécables , 2004 .

[7]  L. Claude,et al.  [Chemoradiation for pancreatic adenocarcinoma]. , 2004, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[8]  V. Vilgrain,et al.  Staging of Pancreatic Head Adenocarcinoma with Spiral CT and Endoscopic Ultrasonography: An Indirect Evaluation of the Usefulness of Laparoscopy , 2004, Pancreatology.

[9]  P. Hammel,et al.  Phase II trial of high dose adjuvant chemo-radiotherapy (55 Gy in 5 wks) after resection of pancreatic adenocarcinoma , 2004 .

[10]  R. Labianca,et al.  GemOx (Gemcitabine + Oxaliplatin) versus Gem (Gemcitabine) in non resectable pancreatic adenocarcinoma : final results of the GERCOR /GISCAD Intergroup Phase III. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Kathryn E. McGoldrick,et al.  Surgeon Volume and Operative Mortality in the United States , 2004 .

[12]  Helen Hickey,et al.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.

[13]  J. Hainsworth,et al.  Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Claude,et al.  Chimioradiothérapie des adénocarcinomes du pancréas exocrine , 2003 .

[15]  T. Saga,et al.  Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) —Usefulness and limitations in “clinical reality”— , 2003, Annals of nuclear medicine.

[16]  B. Gallix.  [Magnetic resonance imaging of the pancreas: value and limits]. , 2003, Gastroenterologie clinique et biologique.

[17]  Conseil Scientifique de La Ffcd.  [What can be done for patients with cancer of the digestive tract in 2003? Guidelines of the Francophone Federation of Digestive Tract Cancerology--part II]. , 2003, Gastroenterologie clinique et biologique.

[18]  J. Pignon,et al.  A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  Martin H. Prins,et al.  A Meta-analysis on the Efficacy of Preoperative Biliary Drainage for Tumors Causing Obstructive Jaundice , 2002, Annals of surgery.

[20]  P. Hammel,et al.  Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A. Hanbidge.  Cancer of the pancreas: the best image for early detection--CT, MRI, PET or US? , 2002, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[22]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[23]  D. Kerr,et al.  Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial , 2001, The Lancet.

[24]  A. Flahault,et al.  Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer. , 2001, Hepato-gastroenterology.

[25]  D. Kerr,et al.  ESPAC-1: A European, randomised study to assess the roles of adjuvant chemotherapy and chemoradiation in resectable pancreatic cancer , 2001 .

[26]  Y. Avni,et al.  The impact of laparoscopy and laparoscopic ultrasonography on the management of pancreatic cancer. , 2000, Archives of Surgery.

[27]  F. Caroli-Bosc,et al.  [Palliative endoscopic treatment of malignant duodenal stenosis by metal prosthesis]. , 2000, Gastroenterologie clinique et biologique.

[28]  H. Friess,et al.  Enteral nutrition prolongs delayed gastric emptying in patients after Whipple resection. , 2000, American journal of surgery.

[29]  C. Degott,et al.  Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses , 2000, Gut.

[30]  J. Jeekel,et al.  Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. , 1999, Annals of surgery.

[31]  M. Sarr.  Treatment of cancer of the exocrine pancreas. , 1999, American journal of surgery.

[32]  K. Lillemoe,et al.  Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. , 1999, Annals of surgery.

[33]  R. Erickson,et al.  Endoscopic ultrasound and fine needle aspiration for the evaluation of pancreatic masses. , 1999, Archives of surgery.

[34]  P. Lin,et al.  Prospective randomized comparison between pylorus‐preserving and standard pancreaticoduodenectomy , 1999, The British journal of surgery.

[35]  K. Dhaene,et al.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. , 1998, Annals of surgery.

[36]  P. Jowell,et al.  Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline. , 1998, Gastrointestinal endoscopy.

[37]  G. Klöppel,et al.  The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas , 1998, Virchows Archiv.

[38]  J Coste,et al.  Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography. , 1998, AJR. American journal of roentgenology.

[39]  M. Heslin,et al.  A preoperative biliary stent is associated with increased complications after pancreatoduodenectomy. , 1998, Archives of surgery.

[40]  T. Ponchon,et al.  Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline , 1998, Gut.

[41]  D. V. Von Hoff,et al.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Jeffrey E. Lee,et al.  Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  T. Linné,et al.  Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[44]  B. Eisenberg,et al.  A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. , 1995, American journal of surgery.

[45]  D. Neuberg,et al.  Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  P. Cotton,et al.  Randomised trial of endoscopic steriting versus surgical bypass in malignant low bileduct obstruction , 1994, The Lancet.

[47]  A. Cull,et al.  Chemotherapy prolongs survival in inoperable pancreatic carcinoma , 1994, The British journal of surgery.

[48]  S. Houry,et al.  Results of resection for cancer of the exocrine pancreas: A study from the French Association of Surgery , 1994, The British journal of surgery.

[49]  C. Charnsangavej,et al.  Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. , 1994, American journal of surgery.

[50]  V. Vilgrain,et al.  Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Adenocarcinoma , 1993, Endoscopy.

[51]  C. Compton,et al.  Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. , 1993, Annals of surgery.

[52]  E. Rosato,et al.  Adjuvant therapy of resected adenocarcinoma of the pancreas. , 1991, International journal of radiation oncology, biology, physics.

[53]  Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group. , 1988, Journal of the National Cancer Institute.

[54]  S. Ellenberg,et al.  Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. , 1985, Archives of surgery.

[55]  P. Engstrom,et al.  Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  J. Barkin,et al.  Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group , 1981, Cancer.

[57]  C. Moertel,et al.  Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. , 1969, Lancet.

[58]  M. Plauchu,et al.  Cancer du pancréas. , 1969 .